A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Myasthenia Gravis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Phoenix Children's Hospital, Phoenix, Arizona, United States

  • Childrens Hospital Los Angeles, Los Angeles, California, United States

  • Lucile Packard Children's Hospital Stanford, Palo Alto, California, United States

  • UCSF Benioff Children's Hospital, San Francisco, California, United States

  • Children's Hospital Colorado, Aurora, Colorado, United States

  • University of South Florida Morsani Center for Advanced Healthcare, Tampa, Florida, United States

  • University of Kansas Medical Center, Lawrence, Kansas, United States

  • C.S. Mott Children's Hospital, Ann Arbor, Michigan, United States

  • Penn State Milton S Hershey Medical Ctr, Hershey, Pennsylvania, United States

  • Childrens Hospital Of Philadelphia, Philadelphia, Pennsylvania, United States

  • University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States

  • Nagano Children's Hospital, Azumino-shi, Japan

  • Chiba University Hospital, Chiba, Japan

  • University of Miyazaki Hospital, Miyazaki, Japan

  • Hyogo College of Medicine Hospital, Nishinomiya-Shi, Japan

  • Saitama Prefecture Children's Medical Center, Saitama Shi, Japan

  • Tokyo Women's Medical University Hospital, Shinjuku-ku, Japan

  • Leiden University Medical Center, Leiden, Netherlands

  • Uniwersyteckie Centrum Kliniczne, Gdansk, Poland

Study leads
  • Janssen Research & Development, LLC Clinical Trial

    Study Director

    Janssen Research & Development, LLC